Godavari Biorefineries jumps nearly 10% after Chinese patent grant for antiviral compound
The patent, titled “Use of Compounds for Treating Viral Infections,” covers compounds that inhibit V-ATPase activity in cells, with applications in manufacturing antiviral medicaments
Shares of Godavari Biorefineries Limited experienced a substantial increase of nearly 10% on Wednesday morning following the announcement of a patent grant from the Chinese Patent Office for an antiviral compound. The stock was trading at ₹248.66 as of 10:36 AM, marking a 9.72% rise from its previous close of ₹226.63. Throughout the trading session, the stock reached a high of ₹258.87 and a low of ₹224.00, which is also its 52-week low.
With a traded volume of 22.27 lakh shares and a traded value of ₹56.06 crore, the company's market capitalization stood at ₹1,271.26 crore. China's National Intellectual Property Administration granted the patent on September 15, 2026. The patent, titled "Use of Compounds for Treating Viral Infections," protects compounds that inhibit V-ATPase activity in cells and can be utilized in the production of antiviral drugs.
Godavari Biorefineries is a constituent of the Nifty Sugar & Ethanol index and had declined by over 14% in the previous year before today's positive development.
Written by urgent.news from Hindu BusinessLine's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
